AMSSM and OpenEvidence Partner to Expand AI-Powered Sports Medicine Resources
Event summary
- American Medical Society for Sports Medicine (AMSSM) partners with OpenEvidence to co-develop AI-powered sports medicine educational resources.
- Resources will be available on SportsMedToday.com and OpenEvidence’s clinician website, which has supported over 200 million AI-powered clinical consultations.
- OpenEvidence becomes AMSSM’s exclusive GenAI partner, combining AI capabilities with human specialist review to enhance educational content.
- The collaboration aims to address musculoskeletal disorders, the second leading reason for U.S. primary care visits.
The big picture
This partnership aligns with the broader trend of AI integration in healthcare, particularly in specialized fields like sports medicine. By combining AMSSM’s expertise with OpenEvidence’s AI capabilities, the collaboration aims to bridge the gap between evolving medical knowledge and patient education. The focus on musculoskeletal disorders, a significant driver of primary care visits, underscores the potential market impact of this initiative.
What we're watching
- Adoption Pace
- How quickly clinicians and patients will integrate the new AI-powered resources into their practices and care routines.
- Content Scale
- Whether the partnership can significantly expand the coverage of sports medicine conditions and update frequency.
- Competitive Response
- How existing and new competitors in clinical decision support will react to this strategic collaboration.
Related topics